|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$4,718,000
|
N/A
|
National Cancer Institute
|
|
Infections, immunity, and inflammation in cancer
|
ZIA CP010150-10059
|
$24,028
|
$24,028
|
A Engels, Eric
|
DCEG (NCI)
|
|
Family Studies
|
ZIA CP004410-08285
|
$964,473
|
$48,224
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
p53 - Regulators and Effectors
|
5P01CA080058-10
|
$1,388,997
|
$486,149
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
CANCER INFORMATION SERVICE
|
N02CO511001-012
|
$1,675,013
|
$442,203
|
ABIDI, SYED
|
SLOAN KETTERING INSTITUTION FOR CANCER R
|
|
Cancer screening among Latinas
|
1R21CA134247-01A1
|
$176,394
|
$176,394
|
ABRAIDO-LANZA, ANA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Radioactive Nanoparticle Immunoconjugates for the Treatment of Solid Tumors
|
5R21CA128421-03
|
$171,000
|
$171,000
|
ADAMS, GREGORY
|
FOX CHASE CANCER CENTER
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-09
|
$1,475,007
|
$590,003
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis
|
5R01CA124940-03
|
$250,515
|
$250,515
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-04
|
$1,045,578
|
$1,045,578
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$135,744
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
|
5SC2CA138179-02
|
|
$0
|
AKALA, EMMANUEL
|
HOWARD UNIVERSITY
|
|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-03
|
$295,736
|
$147,868
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
5R01CA120552-04
|
$241,727
|
$241,727
|
AKPORIAYE, EMMANUEL
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Using Markov Decision Processes to Optimize Breast Biopsy Decision Making
|
5R21CA129393-02
|
$153,320
|
$153,320
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
A Novel Regulator of Cancer Cell Migration and Invasion
|
5R01CA115706-04
|
$195,792
|
$195,792
|
ALAHARI, SURESH
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$38,709
|
Alavanja
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
2P30CA023074-31
|
$4,161,907
|
$1,040,477
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-31S1
|
$105,806
|
$26,452
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-10
|
$511,052
|
$51,105
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-05S1
|
$83,530
|
$20,883
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-05
|
$184,349
|
$46,087
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-007
|
$614,862
|
$162,324
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIV:1107401
|
|
USING TECHNOLOGY TO CONNECT RARELY AND NEVER SCREENED WOMEN TO MAMMOGRAPHY
|
1R03CA142102-01
|
$76,000
|
$76,000
|
Alcaraz, Kassandra
|
WASHINGTON UNIVERSITY
|
|
Understanding Decision-Making in Breast Cancer Reconstruction
|
5R21CA122467-02
|
$173,813
|
$173,813
|
ALDERMAN, AMY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Role of Syndecan-1 in Mouse Mammary Neoplasia
|
5R01CA090877-07
|
$295,173
|
$295,173
|
ALEXANDER, CAROLINE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Systems Analysis of Cell Invasion Induced by Differential Mena Isoform Expression
|
1F32CA142035-01
|
$47,210
|
$47,210
|
Alford, Shannon
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
1K25CA129173-01A2
|
$126,225
|
$126,225
|
Ali, Md
|
HENRY FORD HEALTH SYSTEM
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
5R01CA112519-04
|
$335,460
|
$167,730
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Role of Vitamin D Receptor Polymorphisms in Breast Cancer
|
5F31CA132619-02
|
$35,583
|
$35,583
|
Alimirah, Fatouma
|
ILLINOIS INSTITUTE OF TECHNOLOGY
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
1R01CA139599-01
|
$474,076
|
$237,038
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Neighborhood Characteristics Related to Cancer Risk Factors and Outcomes
|
5R21CA127777-02
|
$201,696
|
$66,560
|
ALLISON, MATTHEW
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Characterization of Human Regulatory T cell-induced Dendritic Cells
|
1F31CA142272-01
|
$41,176
|
$41,176
|
Alonso, Michael
|
STANFORD UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,042,262
|
$20,845
|
Alter
|
DCEG (NCI)
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
1R01CA118005-01A2
|
$340,386
|
$112,327
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Control of Apoptosis in Cancer by Survivin
|
2R01CA078810-12A1
|
$300,885
|
$300,885
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-10
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Antioxidant supplements, genetics, and chemotherapy outcomes
|
5R01CA116395-04
|
$615,542
|
$615,542
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$141,957
|
$141,957
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$182,024
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Image-Guided Stereotactic Radiosurgery of Breast Cancer
|
5R44CA132254-03
|
$1,000,000
|
$1,000,000
|
Amies, Christopher
|
XCISION MEDICAL SYSTEMS, LLC
|
|
Contributions of sleep/rhythms/fatigue to "chemobrain"
|
5R01CA112035-05
|
$391,550
|
$391,550
|
Ancoli-Israel, Sonia
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A biobehavioral intervention for patients with breast cancer recurrence
|
1R21CA135005-01A1
|
$165,000
|
$82,500
|
ANDERSEN, BARBARA
|
OHIO STATE UNIVERSITY
|
|
MAMMARY GLAND BIOLOGY GRC
|
5R13CA128408-03
|
$8,000
|
$8,000
|
ANDERSON, STEVEN
|
GORDON RESEARCH CONFERENCES
|
|
SEER Special Studies
|
ZIA CP010183-10316
|
$161,094
|
$96,656
|
Anderson
|
DCEG (NCI)
|
|
Special Descriptive Studies
|
ZIA CP010183-10348
|
$196,534
|
$196,534
|
Anderson
|
DCEG (NCI)
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-15
|
$720,409
|
$720,409
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5K99CA131489-02
|
$132,965
|
$66,483
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
Biosynthesis of Taxol Precursors in Transgenic Moss
|
1R15CA139416-01
|
$218,250
|
$218,250
|
Anterola, Aldwin
|
SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
|
Total relevant funding to Breast for this search: $599,519,190
|